Related Experiment Video

Updated: Jun 23, 2026

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

Molecular approaches in pediatric oncology

Chand Khanna1, Lee J Helman

  • 1Tumor and Metastasis Biology Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Rockville and Bethesda, Maryland, USA. khannac@mail.nih.gov

Annual Review of Medicine
|January 18, 2006
PubMed

Insights

Molecular approaches are now standard in pediatric cancer care, aiding diagnosis, treatment selection, and monitoring. Pediatric cancer research significantly advances our understanding of cancer biology and its clinical applications.

Area of Science:

  • Pediatric Oncology
  • Molecular Biology
  • Cancer Genomics

Background:

  • Molecular approaches are integral to modern pediatric cancer management.
  • Understanding cancer biology has been significantly advanced by pediatric cancer studies.
  • These molecular insights drive clinical applications in patient care.

Purpose of the Study:

  • To present a model for understanding cancer biology using pediatric oncology examples.
  • To discuss the application of molecular techniques in the clinical management of pediatric cancer.
  • To highlight the role of molecular medicine in improving outcomes for children with cancer.

Main Methods:

  • Review of current molecular techniques in pediatric oncology.
  • Analysis of pediatric cancer studies contributing to cancer biology understanding.
  • Case examples from pediatric oncology to illustrate cancer biology models.

Main Results:

  • Molecular approaches are used for diagnosis, prognosis, therapy selection, toxicity prediction, and monitoring in pediatric cancer.
  • Pediatric cancer research provides crucial insights into fundamental cancer biology.
  • A model for understanding cancer biology is presented with pediatric examples.

Conclusions:

  • Molecular medicine is a cornerstone of contemporary pediatric cancer care.
  • Continued research in pediatric oncology deepens the molecular understanding of cancer.
  • Molecular techniques are essential for personalized and effective management of pediatric malignancies.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...